NASDAQ:BEATW HeartBeam (BEATW) Stock Price, News & Analysis $0.0089 0.00 (-8.24%) Closing price 09/23/2026 03:56 PM EasternExtended Trading$0.01 +0.00 (+2.81%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About HeartBeam Stock (NASDAQ:BEATW) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HeartBeam alerts:Sign Up Key Stats Today's Range$0.0097▼$0.009750-Day Range$0.01▼$0.0452-Week Range$0.01▼$0.56Volume1,108 shsAverage Volume7,656 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview HeartBeam, Inc. is a clinical-stage medical technology company focused on transforming the diagnosis of acute cardiac events through innovative electrocardiogram (ECG) solutions. The company’s core offering leverages proprietary VectorBEAM™ technology to reconstruct a full 12-lead ECG from a compact, three-lead wearable or handheld device. By enabling rapid acquisition and secure transmission of high-fidelity ECG data, HeartBeam’s approach aims to expedite the detection of myocardial ischemia in out-of-hospital settings. HeartBeam’s product ecosystem combines hardware, mobile applications, and cloud-based analytics. The wearable or handheld form factor is designed for use by patients, first responders, and telehealth providers, facilitating real-time triage and remote consultation with cardiovascular specialists. The accompanying software platform supports automated comparisons of current readings against patient-specific baseline ECGs, enhancing the accuracy of ischemia detection and reducing reliance on subjective interpretation. Based in Santa Monica, California, HeartBeam is conducting clinical studies to validate its technology in collaboration with leading medical centers and emergency medical services organizations across the United States. The company’s regulatory strategy has included submissions to the U.S. Food and Drug Administration and engagements with European health authorities in anticipation of broader market access. HeartBeam’s leadership team combines experience in medical device development, cardiovascular clinical research, and digital health commercialization, positioning the company to address critical gaps in early heart attack diagnosis and remote patient monitoring.AI Generated. May Contain Errors. Read More Receive BEATW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HeartBeam and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BEATW Stock News HeadlinesHeartBeam Appoints CEO Robert Eno to BoardMay 5, 2025 | tipranks.comHeartBeam’s Earnings Call Highlights Strategic ProgressMarch 14, 2025 | tipranks.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.September 24 at 1:00 AM | Paradigm Press (Ad)For Raiders' Hated AFC West Rival, Heartbreak Never EndsNovember 11, 2024 | msn.comHeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comBo Watch: Denver rookie QB holds his own against Super Bowl champs … only to lose in heartbreakNovember 10, 2024 | msn.comHeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA SubmissionsNovember 9, 2024 | theglobeandmail.comRob Sheffield's new book on Taylor Swift an emotional jaunt through a layered careerNovember 8, 2024 | usatoday.comSee More Headlines BEATW Stock Analysis - Frequently Asked Questions How have BEATW shares performed this year? HeartBeam's stock was trading at $0.32 on January 1st, 2026. Since then, BEATW stock has decreased by 97.2% and is now trading at $0.0089. How do I buy shares of HeartBeam? Shares of BEATW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/24/2026Next Earnings (Estimated)11/05/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 BEATW's financial health is in the Red zone, according to TradeSmith. BEATW has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:BEATW CIK1779372 Webwww.heartbeam.com Phone408-899-4443FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:BEATW) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartBeam, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartBeam With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.